PGC-1β Induces Susceptibility To Acetaminophen-Driven Acute Liver Failure

Elena Piccinin, Simon Ducheix, Claudia Peres, Maria Arconzo, Maria Carmela Vegliante, Anna Ferretta, Elena Bellafante, Gaetano Villani, Antonio Moschetta

Research output: Contribution to journalArticlepeer-review


Acetaminophen (APAP) is a worldwide commonly used painkiller drug. However, high doses of APAP can lead to acute hepatic failure and, in some cases, death. Previous studies indicated that different factors, including life-style and metabolic diseases, could predispose to the risk of APAP-induced liver failure. However, the molecular process that could favor APAP hepatotoxicity remains understood. Here, we reported that a short-term high fat-enriched diet worsens APAP-induced liver damage, by promoting liver accumulation of lipids that induces the activation of peroxisome proliferator-activated receptor gamma coactivator 1-beta (PGC-1β). Therefore, we challenged mice with hepatic-specific PGC-1β overexpression on a chow diet with a subtoxic dose of APAP and we found that PGC-1β overexpression renders the liver more sensitive to APAP damage, mainly due to intense oxidative stress, finally ending up with liver necrosis and mice death. Overall, our results indicated that during high fat feeding, PGC-1β adversely influences the ability of the liver to overcome APAP toxicity by orchestrating different metabolic pathways that finally lead to fatal outcome.

Original languageEnglish
Article number16821
JournalScientific Reports
Issue number1
Publication statusPublished - Dec 1 2019

ASJC Scopus subject areas

  • General


Dive into the research topics of 'PGC-1β Induces Susceptibility To Acetaminophen-Driven Acute Liver Failure'. Together they form a unique fingerprint.

Cite this